Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
This section ranks key world stock indices and explains the metrics behind rankings, helping readers compare market breadth.
22,503 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Micron Technology presses the AI memory story, delivering strong margins and cloud demand while facing volatility and...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
Adecoagro (AGRO) investors eye the 2025 earnings path as commodity markets, currency volatility, and crop yields shap...
Three AI ETFS split starkly in early 2026: one climbs while another fades, illustrating how fund design shapes AI bet...
Nokia’s stock rally fueled by AI and 6G optimism faces a potential pause as analysts urge profit-taking. Santander tr...
UWM raises its offer for Two Harbors to $12.50 per share in cash or 2.3328 UWMC shares, aiming to derail CrossCountry...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...